Z.M.D. Medical
Immune-based Cancer Treatment
Health Tech & Life Sciences
Non Active, Sep 2021 ceased to operate
Company Overview
Snapshot
Founded in August 2014 by Barak Zigdon and Mark Gaides, Z.M.D. Medical operated with 1-10 employees. The company secured funding across two rounds and received a grant from EU Horizon 2020 in May 2018. Z.M.D. Medical ceased operations in September 2021.
Business overview
Z.M.D. Medical is a Health Tech & Life Sciences company focused on developing immune-based cancer treatments. The company's core product, ONCARIN, is a probiotic preparation designed to rehabilitate distressed colon microflora, thereby enhancing the immune system's ability to eliminate cancer. Operating within the pharmaceuticals and biotechnology sectors, Z.M.D. Medical aims to prevent and reverse cancerous conditions by restoring immune system functionality.
Log in to access full profile ›Company Intelligence Q&A
- What is Z.M.D. Medical's primary focus?
- Z.M.D. Medical focuses on developing therapeutic remedies for cancer treatment by leveraging the patient's immune system, specifically through probiotic preparations.
- When was Z.M.D. Medical founded and by whom?
- Z.M.D. Medical was founded in August 2014 by co-founders Barak Zigdon and Mark Gaides.
- What is ONCARIN?
- ONCARIN is Z.M.D. Medical's probiotic product, consisting of a blend of five lyophilized bacteria species, designed to rehabilitate distressed colon microflora and enhance the immune system's ability to combat cancer.
- What is the current operational status of Z.M.D. Medical?
- Z.M.D. Medical ceased to operate in September 2021.